Protagenic Therapeutics, Inc.\new Retained Earnings
Protagenic Therapeutics, Inc.\new (PTIX) had Retained Earnings of -$4.99 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-19
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$4.99M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$4.03M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$9.11M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$11.32M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$4.99M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | -$4.03M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | -$9.11M 10-Q · filed 2026-03-09 | |
| 2025-09-30 | -$11.32M 10-Q · filed 2025-11-26 | |
| 2025-06-30 | -$10.46M 10-QT · filed 2025-09-10 | |
| 2025-03-31 | -$5.40M 10-K · filed 2026-08-14 | -$37.74M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$36.30M 10-Q · filed 2025-05-13 | |
| 2024-09-30 | -$34.75M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$34.11M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$32.50M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$30.78M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$29.10M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$27.71M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$26.50M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$25.78M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | -$25.18M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$24.25M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$23.58M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$22.22M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$21.33M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$20.45M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$18.91M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$17.70M 10-K · filed 2022-04-07 | |
| 2020-09-30 | -$17.18M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$16.22M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$15.65M 10-Q · filed 2020-06-18 | |
| 2019-12-31 | -$15.15M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$14.40M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$14.28M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$14.00M 10-Q · filed 2019-05-16 | |
| 2018-12-31 | -$13.40M 10-K · filed 2020-04-29 | |
| 2018-09-30 | -$12.61M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$12.11M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$11.44M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$10.84M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$10.15M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$9.69M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$9.24M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$8.58M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$8.03M 10-Q · filed 2016-11-17 | |
| 2016-06-30 | -$7.57M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$7.05M 10-Q · filed 2016-07-25 | |
| 2015-12-31 | -$6.31M 10-K/A · filed 2017-05-08 | -$1.84M 10-Q · filed 2016-03-11 |
| 2015-09-30 | -$1.69M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$1.55M 10-Q · filed 2016-03-11 | |
| 2015-03-31 | -$1.44M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$5.28M 8-K/A · filed 2016-07-12 | -$1.32M 10-Q · filed 2015-02-06 |
| 2014-09-30 | -$1.19M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$1.08M 10-K · filed 2015-09-25 | |
| 2011-09-30 | -$182.23M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$177.71M 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | -$168.05M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |